Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11513727 | 0.95 | CA4 (0.38) | — | |
| SCHEMBL1355989 | 0.86 | CA4 (0.50) | — | |
| SCHEMBL10606866 | 0.85 | CA4 (0.39) | — | |
| SCHEMBL9939567 | 0.82 | BBOX1 (0.43) | — | |
| SCHEMBL11677216 | 0.81 | CA4 (0.45) | — | |
| SCHEMBL8186347 | 0.81 | BBOX1 (0.46) | — | |
| SCHEMBL112322 | 0.80 | — | — | |
| SCHEMBL29707468 | 0.80 | CA4 (0.50) | — | |
| SCHEMBL10610542 | 0.80 | KDM4E (0.35) | — | |
| SCHEMBL284370 | 0.80 | CA4 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4240316-A1 | STYLING SHAMPOO COMPOSITIONS | BASF SE (DE) | 2023-09-13 | — | — | EP | claimed |
| WO-2022228806-A1 | BIPHASIC COSMETIC COMPOSITION AND APPLICATION THEREOF | BASF SE (DE) | 2022-11-03 | — | — | WO | claimed |
| WO-2022096243-A1 | STYLING SHAMPOO COMPOSITIONS | BASF SE (DE) | 2022-05-12 | — | — | WO | claimed |
| EP-1282596-B1 | PREPARATION OF IMINODIACETIC ACID COMPOUNDS FROM MONOETHANOLAMINE SUBSTRATES | MONSANTO TECHNOLOGY LLC (US) | 2006-08-30 | — | — | EP | claimed |
| CN-1436167-A | Preparation of iminodiacetic acid compounds from monoethanolamine | MONSANTO TECHNOLOGY LLC (US) | 2003-08-13 | — | — | CN | claimed |
| US-6555706-B2 | Cyanoethylation, hydrolysis, dehydrogenation of ethanolamine | MONSANTO COMPANY | 2003-04-29 | — | — | US | claimed |
| EP-1282596-A1 | PREPARATION OF IMINODIACETIC ACID COMPOUNDS FROM MONOETHANOLAMINE SUBSTRATES | Monsanto Technology LLC (US) | 2003-02-12 | — | — | EP | claimed |
| US-20020019565-A1 | Process for making iminodiacetic acid compounds from monoethanolamine substrates | MONSANTO TECHNOLOGY LLC | 2002-02-14 | — | — | US | claimed |
| WO-2001087827-A1 | PREPARATION OF IMINODIACETIC ACID COMPOUNDS FROM MONOETHANOLAMINE SUBSTRATES | MONSANTO TECHNOLOGY LLC (US) | 2001-11-22 | — | — | WO | claimed |
| EP-4443155-B1 | ENCAPSULATED PRE-ANALYTIC WORKFLOWS FOR FLOW-THROUGH DEVICES, LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRIC ANALYSIS | WATERS TECHNOLOGIES CORP (US) | 2026-05-13 | — | — | EP | disclosed |
| WO-2026089753-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF CARNOSINE FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026089754-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108582-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF CARNOSINE FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-4931067-A | Method or dyeing using phase change dyestuffs | SRI INTERNATIONAL (US) | 1990-06-05 | — | — | US | disclosed |
| US-4914232-A | FOR POLYMERS | THE B. F. GOODRICH COMPANY (US) | 1990-04-03 | — | — | US | disclosed |
| EP-0306526-A1 | PHASE CHANGE DYESTUFFS | SRI INTERNATIONAL (US) | 1989-03-15 | — | — | EP | disclosed |
| WO-1988007568-A1 | PHASE CHANGE DYESTUFFS | SRI INTERNATIONAL (US) | 1988-10-06 | — | — | WO | disclosed |
| US-4540443-A | Cooling system cleaning composition | UNION CARBIDE CORPORATION (US) | 1985-09-10 | — | — | US | disclosed |
| US-4528370-A | Polysubstituted 2-morpholones | NOVEON IP HOLDINGS CORP., FORMERLY KNOWN AS PMD HOLDINGS CORP. | 1985-07-09 | — | — | US | disclosed |